Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study (Health Technology Assessment, 2022)

(untitled) - Gould, DW; Doidge, J; Sadique, MZ; Borthwick, M; Hatch, R; Caskey, FJ; Forni, L; Lawrence, RF; MacEwen, C; Ostermann, M; Mouncey, PR; Harrison, DA; et al.